Cited by 138Thyroid Disorders and TreatmentsChronic Kidney Disease and DiabetesThyroid and Parathyroid Surgery

Preservation of Renal Function by Thyroid Hormone Replacement Therapy in Chronic Kidney Disease Patients with Subclinical Hypothyroidism

Shin, Dong Ho, Lee, Mi Jung, Kim, Seung Jun, Oh, Hyung Jung, Kim, Hyoung Rae, Han, Jae Hyun, Koo, Hyang Mo, Doh, Fa Mee +4 more·2012·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Subclinical hypothyroidism is not a rare condition, but the use of thyroid hormone to treat subclinical hypothyroidism is an issue of debate. Objective: This study was undertaken to investigate the impact of thyroid hormone therapy on the changes in estimated glomerular filtration rate (eGFR) in subclinical hypothyroidism patients with stage 2–4 chronic kidney disease. Patients: A total of 309 patients were included in the final analysis. Main Outcome Measure: The changes in eGFR over time were compared between patients with and without thyroid hormone replacement therapy using a linear mixed model. Kaplan-Meier curves were constructed to determine the effect of thyroid hormone on renal outcome, a reduction of eGFR by 50%, or end-stage renal disease. The independent prognostic value of subclinical hypothyroidism treatment for renal outcome was ascertained by multivariate Cox regression analysis. Results: Among the 309 patients, 180 (58.3%) took thyroid hormone (treatment group), whereas 129 (41.7%) did not (nontreatment group). During the mean follow-up duration of 34.8 ± 24.3 months, the overall rate of decline in eGFR was significantly greater in the nontreatment group compared to the treatment group (−5.93 ± 1.65 vs. −2.11 ± 1.12 ml/min/yr/1.73 m2; P = 0.04). Moreover, a linear mixed model revealed that there was a significant difference in the rates of eGFR decline over time between the two groups (P < 0.01). Kaplan-Meier analysis also showed that renal event-free survival was significantly lower in the nontreatment group (P < 0.01). In multivariate Cox regression analysis, thyroid hormone replacement therapy was found to be an independent predictor of renal outcome (hazard ratio, 0.28; 95% CI, 0.12–0.68; P = 0.01). Conclusion: Thyroid hormone therapy not only preserved renal function better, but was also an independent predictor of renal outcome in chronic kidney disease patients with subclinical hypothyroidism.

Integrity signals

Registry

Crossref · 10.1210/jc.2012-1663

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of LT4 has been observed to improve renal function, in one study improving odds of progression and lowering the incidence of end-stage kidney disease by limiting the rate of decline in glomerular filtration rate.

    “Administration of LT4 has been observed to improve renal function, in one study improving odds of progression and lowering the incidence of end-stage kidney disease by limiting the rate of decline in glomerular filtration rate”

    From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [123]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shin, D. H., Lee, M. J., Kim, S. J., Oh, H. J., Kim, H. R., Han, J. H., Koo, H. M., Doh, F. M., Park, J. T., Han, S. H., Yoo, T.-H., & Kang, S.-W.
Affiliations
  • Department of Internal Medicine, College of Medicine (D.H.S., M.J.L., S.J.K., H.J.O., H.R.K., J.H.H., H.M.K., F.M.D., J.T.P., S.H.H., T.-H.Y., S.-W.K.), Seoul 120-752, Korea
  • Yonsei University (KR)
Corresponding author
Kang, Shin-Wook
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-08-01
Volume
97
Issue
8
Pages
2732-2740
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1979350914
Cited by
138
References
47
Citations by year
2026: 6 · 2025: 12 · 2024: 8 · 2023: 9 · 2022: 12 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 12 · 2017: 9 · 2016: 8 · 2015: 5 · 2014: 16 · 2013: 13 · 2012: 1
FWCI
8.97
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
subclinical hypothyroidism, thyroid hormone replacement, chronic kidney disease, estimated glomerular filtration rate decline, renal function preservation, end-stage renal disease, renal outcomes, prognostic factors
MeSH terms
Adult, Aged, Blood Pressure, Chronic Disease, Female, Glomerular Filtration Rate, Humans, Hypothyroidism, Iodide Peroxidase, Kidney Diseases, Male, Middle Aged, Thyroid Hormones, Thyrotropin, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review